Another recent systematic review found little evidence that CBD could reduce symptoms of schizophrenia at high doses. The review notes that a 4-week trial with 800 milligrams (mg) of CBD yielded results similar to those of amisulpride, an antipsychotic medication, for relieving psychosis and improving cognition. Effects of CBD on schizophrenia The next step was to evaluate the effects of CBD on a patient with schizophrenia. Therefore, well-designed randomized trials with larger samples using reliable, high-quality CBD are needed to determine the efficacy and safety of CBD as an antipsychotic drug and for it to be approved by the FDA for use in schizophrenia.
Antipsychotic properties of CBD In 1982, a study on interactions between THC and CBD in healthy volunteers provided the first evidence that CBD could have antipsychotic properties. For the first time, the brains of people with a diagnosis of psychosis who have taken CBD have been scanned, providing important information about the areas of the brain that CBD targets. The study also showed that psychotic symptoms showed a downward trend after the dose of CBD, but the researchers highlighted that no definitive conclusions could be drawn about this effect, since the study did not analyze the sustained use of CBD and the sample size was small. The placebo group showed more improvement than the CBD group, and those who took CBD developed more symptoms of sedation.
There is some human research on CBD and schizophrenia, but there isn't enough evidence to conclude that CBD should be used for schizophrenia. CBD can be easily purchased in most parts of the U.S. In the United States, raising concerns about the use of CBD enriched with cannabis in an artisanal and uncontrolled way. In addition, since over-the-counter CBD products are not regulated by the Food and Drug Administration (FDA) to ensure their safety, a CBD product may contain more THC than advertised.
This is the first time that the brains of people diagnosed with psychosis who have taken CBD have been scanned and, although the sample is small, the results are convincing, since they show that CBD influences those same areas of the brain that have been shown to have unusual activity in people with psychosis. The initial observation that CBD reduced psychotic symptoms induced by THC led us to carry out a pioneering study to test the effects of CBD in a model commonly used to identify drugs with an antipsychotic profile in laboratory animals. PlusCBD is a CBD company that offers a wide range of CBD products and potencies, including gummies, topical products, oils and more. Effects of CBD on Parkinson's psychosis It seems that the antipsychotic effect of CBD is not limited to patients with schizophrenia.
